The Global Zafirlukast API Market was valued at USD 112.8 Million in 2024 and is projected to reach USD 163.5 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period (2024–2030). This growth is being driven by increasing asthma prevalence, rising demand for leukotriene receptor antagonists, and the accelerating adoption of biosimilars and cost-effective generic alternatives across developed and emerging pharmaceutical markets.

As the respiratory therapeutics industry evolves toward more targeted and personalized treatment approaches, the spotlight is on the key Active Pharmaceutical Ingredient (API) manufacturers who are driving innovation, quality, and manufacturing efficiency. In this blog, we profile the Top 10 Companies in the Zafirlukast API Industry—a mix of established pharmaceutical giants and specialized API producers shaping the future of asthma management globally.

---

🔟 1. Hetero Drugs Limited

Headquarters: Hyderabad, Telangana, India
Key Offering: Zafirlukast API (Above 98% and Above 99% purity grades)

Hetero Drugs is among the world’s leading manufacturers of Zafirlukast API, supplying high-purity active ingredients to formulation companies worldwide. Their advanced manufacturing facilities and robust R&D capabilities enable them to maintain high-quality standards while meeting increasing market demand for this critical asthma medication component.

Manufacturing Capabilities:

• Multiple GMP-certified manufacturing plants

• Strategic partnerships with global pharmaceutical companies

• Extensive global distribution network across 120+ countries

Download FREE Sample Report:
Zafirlukast API Market – View in Detailed Research Report

---

9️⃣ 2. Dr. Reddy’s Laboratories Ltd.

Headquarters: Hyderabad, Telangana, India
Key Offering: Zafirlukast API, Finished Dosage Forms

Dr. Reddy’s Laboratories has established itself as a key supplier of Zafirlukast API with robust manufacturing capabilities and stringent quality control processes that meet international regulatory standards.

Manufacturing Capabilities:

• Integrated pharmaceutical company with strong API manufacturing base

• Active pharmaceutical development pipeline for respiratory therapeutics

---

8️⃣ 3. Chromo Laboratories India Pvt. Ltd.

Headquarters: Mumbai, Maharashtra, India
Key Offering: Zafirlukast API in various purity grades

Chromo Laboratories specializes in the development and manufacturing of high-quality APIs, including Zafirlukast, with a focus on process optimization and cost efficiency.

Manufacturing Capabilities:

• Focus on process development and scale-up capabilities

• Strong expertise in chemical synthesis and purification technologies

---

7️⃣ 4. Synergene Active Ingredients Pvt. Ltd.

Headquarters: Bengaluru, Karnataka, India
Key Offering: Zafirlukast API and intermediate products

Synergene Active Ingredients has emerged as a significant player in the Zafirlukast API market, leveraging its technical expertise in complex organic synthesis and regulatory compliance.

Manufacturing Capabilities:

• Specialized in niche and complex API manufacturing

• Strong focus on research and process innovation

Download FREE Sample Report:
Zafirlukast API Market – View in Detailed Research Report

---

6️⃣ 5. Apollo Pharmaceuticals

Headquarters: Chennai, Tamil Nadu, India
Key Offering: Zafirlukast API and finished formulations

Apollo Pharmaceuticals has expanded its API manufacturing portfolio to include Zafirlukast, complementing its existing respiratory therapeutics offerings and expanding its global market presence.

Manufacturing Capabilities:

• Vertically integrated pharmaceutical company

• Growing presence in emerging markets for asthma therapeutics

---

5️⃣ 6. Cipla Limited

Headquarters: Mumbai, Maharashtra, India
Key Offering: Zafirlukast API for domestic and international markets

Cipla has leveraged its strong presence in respiratory medicine to expand into Zafirlukast API manufacturing, supporting both branded and generic formulations globally.

Manufacturing Capabilities:

• Strong respiratory therapeutics portfolio

• Focus on affordable healthcare solutions

---

4️⃣ 7. Sun Pharmaceutical Industries Ltd.

Headquarters: Mumbai, Maharashtra, India
Key Offering: Zafirlukast API and finished dosage forms

Sun Pharma, as one of the world’s largest specialty generic pharmaceutical companies, has integrated Zafirlukast API into its comprehensive respiratory product portfolio.

Manufacturing Capabilities:

• Global manufacturing footprint with multiple regulatory approvals

• Strong R&D investments in respiratory medicine

---

3️⃣ 8. Aurobindo Pharma Limited

Headquarters: Hyderabad, Telangana, India
Key Offering: Zafirlukast API for generic pharmaceutical markets

Aurobindo Pharma has developed significant capabilities in Zafirlukast API manufacturing, benefiting from its scale and vertical integration across the pharmaceutical value chain.

Manufacturing Capabilities:

• Vertically integrated manufacturing capabilities

• Focus on cost-effective API production

---

2️⃣ 9. Mylan Laboratories (Now Viatris)

Headquarters: Canonsburg, Pennsylvania, USA (Global operations including India)
Key Offering: Zafirlukast API under Viatris portfolio

Viatris (formerly Mylan) maintains a significant presence in the Zafirlukast API market through its global manufacturing network and established pharmaceutical distribution channels.

Manufacturing Capabilities:

• Global manufacturing and distribution network

• Strong regulatory compliance and quality management systems

---

1️⃣ 10. Lupin Limited

Headquarters: Mumbai, Maharashtra, India
Key Offering: Zafirlukast API and respiratory therapeutic products

Lupin has established itself as a reliable supplier of Zafirlukast API, leveraging its expertise in complex molecule synthesis and manufacturing process optimization.

Manufacturing Capabilities:

• Strong respiratory and asthma therapeutic focus

• Growing API manufacturing capabilities for specialty generics

Get Full Report Here:
Zafirlukast API Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Zafirlukast API Is Driven by Innovation and Accessibility

The Zafirlukast API market is undergoing a significant transformation. While traditional manufacturing processes still dominate, the industry is investing in process optimization, green chemistry, and manufacturing automation to enhance efficiency, reduce costs, and improve product quality for global asthma patients.

📈 Key Trends Shaping the Market:

• Increasing asthma prevalence driving demand for leukotriene receptor antagonists

• Regulatory push for affordable generic alternatives in healthcare systems

• Integration of advanced analytical techniques for quality control and assurance

• Growing biosimilar and generic API manufacturing capacity in Asia-Pacific

• Shift toward patient-centric therapeutic approaches in respiratory medicine

Get Full Report Here:
Zafirlukast API Market – View in Detailed Research Report

The companies listed above are not only supplying critical APIs for asthma treatment—they’re advancing the global accessibility of essential respiratory medications.